{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T13:32:06Z","timestamp":1789565526978,"version":"build-2803163510"},"reference-count":155,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["2042019kf0058"],"award-info":[{"award-number":["2042019kf0058"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82100331"],"award-info":[{"award-number":["82100331"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003819","name":"Natural Science Foundation of Hubei Province","doi-asserted-by":"publisher","award":["2023AFB797"],"award-info":[{"award-number":["2023AFB797"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003819","name":"Natural Science Foundation of Hubei Province","doi-asserted-by":"publisher","award":["2022020801020484"],"award-info":[{"award-number":["2022020801020484"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.lfs.2024.122903","type":"journal-article","created":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T00:18:29Z","timestamp":1720484309000},"page":"122903","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Role of angiotensin converting enzyme in pathogenesis associated with immunity in cardiovascular diseases"],"prefix":"10.1016","volume":"352","author":[{"given":"Xinyi","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huasheng","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaoke","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2024.122903_bb0005","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/s41591-018-0064-0","article-title":"Myeloid cell contributions to cardiovascular health and disease","volume":"24","author":"Nahrendorf","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.lfs.2024.122903_bb0010","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.cjca.2020.01.013","article-title":"Inflammation in hypertension","volume":"36","author":"Xiao","year":"2020","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.lfs.2024.122903_bb0015","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1161\/CIRCRESAHA.120.316903","article-title":"Meta-analysis of leukocyte diversity in atherosclerotic mouse aortas","volume":"127","author":"Zernecke","year":"2020","journal-title":"Circ. Res."},{"key":"10.1016\/j.lfs.2024.122903_bb0020","first-page":"2537","article-title":"Heterogeneity of immune cells in human atherosclerosis revealed by scRNA-Seq","volume":"117","author":"Vallejo","year":"2021","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.lfs.2024.122903_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106934","article-title":"The role of macrophages in pulmonary hypertension: pathogenesis and targeting","volume":"88","author":"Chen","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.lfs.2024.122903_bb0030","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00441-020-03409-0","article-title":"Immune mechanisms in arterial hypertension","volume":"385","author":"Wenzel","year":"2021","journal-title":"Recent advances, Cell Tissue Res."},{"key":"10.1016\/j.lfs.2024.122903_bb0035","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/3647817","article-title":"The PD-1 with PD-L1 Axis is pertinent with the immune modulation of atrial fibrillation by regulating T cell excitation and promoting the secretion of inflammatory factors","volume":"2022","author":"Chang","year":"2022","journal-title":"J Immunol Res"},{"key":"10.1016\/j.lfs.2024.122903_bb0040","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.817514","article-title":"Pro-inflammatory derangement of the Immuno-Interactome in heart failure","volume":"13","author":"Kumar","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2024.122903_bb0045","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1052850","article-title":"Bioinformatics and systems biology approaches to identify molecular targeting mechanism influenced by COVID-19 on heart failure","volume":"13","author":"Yang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2024.122903_bb0050","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s12565-016-0372-8","article-title":"Renin-angiotensin system in vertebrates: phylogenetic view of structure and function","volume":"92","author":"Nishimura","year":"2017","journal-title":"Anat. Sci. Int."},{"key":"10.1016\/j.lfs.2024.122903_bb0055","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1161\/01.HYP.0000050650.52007.83","article-title":"Mice lacking endothelial ACE: Normal blood pressure with elevated angiotensin II","volume":"41","author":"Cole","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.lfs.2024.122903_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/pr.112.006809","article-title":"A modern understanding of the traditional and nontraditional biological functions of angiotensin-converting enzyme","volume":"65","author":"Bernstein","year":"2013","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.lfs.2024.122903_bb0065","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.2353\/ajpath.2007.061205","article-title":"Mice with enhanced macrophage angiotensin-converting enzyme are resistant to melanoma","volume":"170","author":"Shen","year":"2007","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.lfs.2024.122903_bb0070","doi-asserted-by":"crossref","first-page":"39051","DOI":"10.1074\/jbc.M110.163782","article-title":"Angiotensin-converting enzyme overexpression in mouse myelomonocytic cells augments resistance to Listeria and methicillin-resistant Staphylococcus aureus","volume":"285","author":"Okwan-Duodu","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2024.122903_bb0075","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1182\/blood-2016-11-752006","article-title":"Angiotensin-converting enzyme enhances the oxidative response and bactericidal activity of neutrophils","volume":"130","author":"Khan","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.lfs.2024.122903_bb0080","doi-asserted-by":"crossref","first-page":"4368","DOI":"10.1074\/jbc.RA118.006275","article-title":"Overexpression of the C-domain of angiotensin-converting enzyme reduces melanoma growth by stimulating M1 macrophage polarization","volume":"294","author":"Khan","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2024.122903_bb0085","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1172\/JCI66541","article-title":"Angiotensin-converting enzyme overexpression in myelomonocytes prevents Alzheimer\u2019s-like cognitive decline","volume":"124","author":"Bernstein","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.lfs.2024.122903_bb0090","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.bbrc.2019.10.078","article-title":"Overexpression of myeloid angiotensin-converting enzyme (ACE) reduces atherosclerosis","volume":"520","author":"Okwan-Duodu","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.lfs.2024.122903_bb0095","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1093\/brain\/awz364","article-title":"Peripherally derived angiotensin converting enzyme-enhanced macrophages alleviate Alzheimer-related disease","volume":"143","author":"Koronyo-Hamaoui","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.lfs.2024.122903_bb0100","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1096\/fj.10-169433","article-title":"Angiotensin-converting enzyme is required for normal myelopoiesis","volume":"25","author":"Lin","year":"2011","journal-title":"FASEB J."},{"key":"10.1016\/j.lfs.2024.122903_bb0105","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrneph.2018.15","article-title":"Angiotensin-converting enzyme in innate and adaptive immunity","volume":"14","author":"Bernstein","year":"2018","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.lfs.2024.122903_bb0110","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1172\/JCI119419","article-title":"The critical role of tissue angiotensin-converting enzyme as revealed by gene targeting in mice","volume":"99","author":"Esther","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.lfs.2024.122903_bb0115","doi-asserted-by":"crossref","first-page":"9002","DOI":"10.1016\/S0021-9258(18)31543-6","article-title":"The two homologous domains of human angiotensin I-converting enzyme are both catalytically active","volume":"266","author":"Wei","year":"1991","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2024.122903_bb0120","doi-asserted-by":"crossref","first-page":"11945","DOI":"10.1016\/S0021-9258(18)80158-2","article-title":"Mouse angiotensin-converting enzyme is a protein composed of two homologous domains","volume":"264","author":"Bernstein","year":"1989","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2024.122903_bb0125","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1007\/s00109-013-1051-z","article-title":"Rediscovering ACE: novel insights into the many roles of the angiotensin-converting enzyme","volume":"91","author":"Gonzalez-Villalobos","year":"2013","journal-title":"J. Mol. Med. (Berl)"},{"key":"10.1016\/j.lfs.2024.122903_bb0130","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/j.exphem.2003.08.018","article-title":"Angiotensin-converting enzyme (CD143) is abundantly expressed by dendritic cells and discriminates human monocyte-derived dendritic cells from acute myeloid leukemia-derived dendritic cells","volume":"31","author":"Danilov","year":"2003","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.lfs.2024.122903_bb0135","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/labinvest.2017.32","article-title":"Angiotensin-converting enzyme affects the presentation of MHC class II antigens","volume":"97","author":"Zhao","year":"2017","journal-title":"Lab. Investig."},{"key":"10.1016\/j.lfs.2024.122903_bb0140","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1161\/01.HYP.21.2.155","article-title":"Bradykinin peptides in kidney, blood, and other tissues of the rat","volume":"21","author":"Campbell","year":"1993","journal-title":"Hypertension"},{"key":"10.1016\/j.lfs.2024.122903_bb0145","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/ni.2107","article-title":"The carboxypeptidase ACE shapes the MHC class I peptide repertoire","volume":"12","author":"Shen","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.lfs.2024.122903_bb0150","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1681\/ASN.2016101066","article-title":"Immunologic effects of the renin-angiotensin system","volume":"28","author":"Crowley","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.lfs.2024.122903_bb0155","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1093\/ajh\/hpac077","article-title":"Update on immune mechanisms in hypertension","volume":"35","author":"Navaneethabalakrishnan","year":"2022","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.lfs.2024.122903_bb0160","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s11906-019-1008-x","article-title":"Overexpression of ACE in myeloid cells increases immune effectiveness and leads to a new way of considering inflammation in acute and chronic diseases","volume":"22","author":"Veiras","year":"2020","journal-title":"Curr. Hypertens. Rep."},{"key":"10.1016\/j.lfs.2024.122903_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2021.111257","article-title":"Novel roles of the renal angiotensin-converting enzyme","volume":"529","author":"Giani","year":"2021","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.lfs.2024.122903_bb0170","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/9028969","article-title":"Exploring the impact of ACE inhibition in immunity and disease","volume":"2022","author":"Oosthuizen","year":"2022","journal-title":"J. Renin-Angiotensin-Aldosterone Syst."},{"key":"10.1016\/j.lfs.2024.122903_bb0175","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/labinvest.2014.41","article-title":"Myeloid expression of angiotensin-converting enzyme facilitates myeloid maturation and inhibits the development of myeloid-derived suppressor cells","volume":"94","author":"Shen","year":"2014","journal-title":"Lab. Investig."},{"key":"10.1016\/j.lfs.2024.122903_bb0180","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/S0021-9258(17)49895-4","article-title":"ACE overexpression in myeloid cells increases oxidative metabolism and cellular ATP","volume":"295","author":"Cao","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2024.122903_bb0185","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ijrobp.2022.01.023","article-title":"Pharmacologic ACE-inhibition mitigates radiation-induced pneumonitis by suppressing ACE-expressing lung myeloid cells","volume":"113","author":"Sharma","year":"2022","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.lfs.2024.122903_bb0190","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abj2138","article-title":"An ACE inhibitor reduces bactericidal activity of human neutrophils in vitro and impairs mouse neutrophil activity in vivo","volume":"13","author":"Cao","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.lfs.2024.122903_bb0195","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2019-000487","article-title":"Immunomodulatory effects of renin-angiotensin system inhibitors on T lymphocytes in mice with colorectal liver metastases","volume":"8","author":"Vallejo Ardila","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.lfs.2024.122903_bb0200","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1158\/0008-5472.CAN-05-1299","article-title":"Gr-1+CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host","volume":"66","author":"Huang","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.lfs.2024.122903_bb0205","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.phrs.2017.03.017","article-title":"The interplay between angiotensin II, TLR4 and hypertension","volume":"120","author":"Biancardi","year":"2017","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.lfs.2024.122903_bb0210","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1159\/000479272","article-title":"Angiotensin II regulates dendritic cells through activation of NF-\u03baB\/p65, ERK1\/2 and STAT1 pathways","volume":"42","author":"Meng","year":"2017","journal-title":"Cellular Physiology and Biochemistry: International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology"},{"key":"10.1016\/j.lfs.2024.122903_bb0215","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.freeradbiomed.2020.02.002","article-title":"Angiotensin II and leukocyte trafficking: new insights for an old vascular mediator. Role of redox-signaling pathways","volume":"157","author":"Piqueras","year":"2020","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.lfs.2024.122903_bb0220","doi-asserted-by":"crossref","first-page":"R208","DOI":"10.1152\/ajpregu.90521.2008","article-title":"Regulation of T-cell function by endogenously produced angiotensin II","volume":"296","author":"Hoch","year":"2009","journal-title":"Regulatory, Integrative and Comparative Physiology"},{"key":"10.1016\/j.lfs.2024.122903_bb0225","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1172\/JCI61368","article-title":"Type 1 angiotensin receptors on macrophages ameliorate IL-1 receptor-mediated kidney fibrosis","volume":"124","author":"Zhang","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.lfs.2024.122903_bb0230","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2211370119","article-title":"Angiotensin II enhances bacterial clearance via myeloid signaling in a murine sepsis model","volume":"119","author":"Leisman","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.lfs.2024.122903_bb0235","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20211001","article-title":"Angiotensin II enhances group 2 innate lymphoid cell responses via AT1a during airway inflammation","volume":"219","author":"Liu","year":"2022","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.lfs.2024.122903_bb0240","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1111\/j.1398-9995.2011.02686.x","article-title":"New topics in bradykinin research","volume":"66","author":"Maurer","year":"2011","journal-title":"Allergy"},{"key":"10.1016\/j.lfs.2024.122903_bb0245","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.cca.2021.10.029","article-title":"Angiotensin converting enzyme (ACE)","volume":"524","author":"Khurana","year":"2022","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.lfs.2024.122903_bb0250","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1161\/01.RES.0000038114.17939.C8","article-title":"CK2 phosphorylates the angiotensin-converting enzyme and regulates its retention in the endothelial cell plasma membrane","volume":"91","author":"Kohlstedt","year":"2002","journal-title":"Circ. Res."},{"key":"10.1016\/j.lfs.2024.122903_bb0255","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1161\/01.RES.0000107195.13573.E4","article-title":"Angiotensin-converting enzyme is involved in outside-in signaling in endothelial cells","volume":"94","author":"Kohlstedt","year":"2004","journal-title":"Circ. Res."},{"key":"10.1016\/j.lfs.2024.122903_bb0260","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1080\/10408363.2021.1942782","article-title":"Evaluation of pathophysiological relationships between renin-angiotensin and ACE-ACE2 systems in cardiovascular disorders: from theory to routine clinical practice in patients with heart failure","volume":"58","author":"Aimo","year":"2021","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"10.1016\/j.lfs.2024.122903_bb0265","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/s41590-018-0113-3","article-title":"Regulation of macrophage immunometabolism in atherosclerosis","volume":"19","author":"Koelwyn","year":"2018","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.lfs.2024.122903_bb0270","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1161\/CIRCRESAHA.118.314028","article-title":"Tissue resident CCR2- and CCR2+ cardiac macrophages differentially orchestrate monocyte recruitment and fate specification following myocardial injury","volume":"124","author":"Bajpai","year":"2019","journal-title":"Circ. Res."},{"key":"10.1016\/j.lfs.2024.122903_bb0275","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/nbt.1989","article-title":"Therapeutic siRNA silencing in inflammatory monocytes in mice","volume":"29","author":"Leuschner","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.lfs.2024.122903_bb0280","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1161\/ATVBAHA.114.303214","article-title":"Vascular smooth muscle cell-derived transforming growth factor-beta promotes maturation of activated, neointima lesion-like macrophages","volume":"34","author":"Ostriker","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.lfs.2024.122903_bb0285","doi-asserted-by":"crossref","first-page":"16457","DOI":"10.1073\/pnas.1104533108","article-title":"Myeloid-specific estrogen receptor alpha deficiency impairs metabolic homeostasis and accelerates atherosclerotic lesion development","volume":"108","author":"Ribas","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.lfs.2024.122903_bb0290","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1161\/CIRCRESAHA.118.312804","article-title":"Transcriptome analysis reveals nonfoamy rather than foamy plaque macrophages are Proinflammatory in atherosclerotic murine models","volume":"123","author":"Kim","year":"2018","journal-title":"Circ. Res."},{"key":"10.1016\/j.lfs.2024.122903_bb0295","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1161\/01.ATV.0000166517.18801.a7","article-title":"Phagocytosis of apoptotic cells by macrophages is impaired in atherosclerosis","volume":"25","author":"Schrijvers","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.lfs.2024.122903_bb0300","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1161\/CIRCRESAHA.116.309692","article-title":"Neutrophil extracellular traps in atherosclerosis and Atherothrombosis","volume":"120","author":"Doring","year":"2017","journal-title":"Circ. Res."},{"key":"10.1016\/j.lfs.2024.122903_bb0305","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1161\/CIRCRESAHA.118.313591","article-title":"Immunity and inflammation in atherosclerosis","volume":"124","author":"Wolf","year":"2019","journal-title":"Circ. Res."},{"key":"10.1016\/j.lfs.2024.122903_bb0310","article-title":"Immune mechanisms of plaque instability","volume":"8","author":"Gerhardt","year":"2021","journal-title":"Front Cardiovasc Med."},{"key":"10.1016\/j.lfs.2024.122903_bb0315","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.121.008997","article-title":"Estrogen receptor-beta agonists modulate T-lymphocyte activation and ameliorate left ventricular remodeling during chronic heart failure","volume":"15","author":"Rosenzweig","year":"2022","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.lfs.2024.122903_bb0320","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1084\/jem.20070657","article-title":"Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction","volume":"204","author":"Guzik","year":"2007","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.lfs.2024.122903_bb0325","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1161\/HYPERTENSIONAHA.114.03663","article-title":"Sex-specific T-cell regulation of angiotensin II-dependent hypertension","volume":"64","author":"Ji","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.lfs.2024.122903_bb0330","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1161\/HYPERTENSIONAHA.116.07237","article-title":"Activation of human T cells in hypertension: studies of humanized mice and hypertensive humans","volume":"68","author":"Itani","year":"2016","journal-title":"Hypertension"},{"key":"10.1016\/j.lfs.2024.122903_bb0335","doi-asserted-by":"crossref","first-page":"4642","DOI":"10.1172\/JCI74084","article-title":"DC isoketal-modified proteins activate T cells and promote hypertension","volume":"124","author":"Kirabo","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.lfs.2024.122903_bb0340","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1093\/cvr\/cvy112","article-title":"Hypertension and increased endothelial mechanical stretch promote monocyte differentiation and activation: roles of STAT3, interleukin 6 and hydrogen peroxide","volume":"114","author":"Loperena","year":"2018","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.lfs.2024.122903_bb0345","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.immuni.2013.08.007","article-title":"Minimal differentiation of classical monocytes as they survey steady-state tissues and transport antigen to lymph nodes","volume":"39","author":"Jakubzick","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.lfs.2024.122903_bb0350","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1002\/cphy.c200020","article-title":"Innate immune cells and hypertension: neutrophils and neutrophil extracellular traps (NETs)","volume":"11","author":"McCarthy","year":"2021","journal-title":"Compr. Physiol."},{"key":"10.1016\/j.lfs.2024.122903_bb0355","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1111\/jcmm.12467","article-title":"PD-1\/PD-L1 expression on CD(4+) T cells and myeloid DCs correlates with the immune pathogenesis of atrial fibrillation","volume":"19","author":"Liu","year":"2015","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.lfs.2024.122903_bb0360","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.900810","article-title":"Dominant myocardial fibrosis and complex immune microenvironment jointly shape the pathogenesis of Arrhythmogenic right ventricular cardiomyopathy","volume":"9","author":"Lu","year":"2022","journal-title":"Front Cardiovasc Med."},{"key":"10.1016\/j.lfs.2024.122903_bb0365","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/eurheartj\/ehi668","article-title":"Role of angiotensin system and effects of its inhibition in atrial fibrillation: clinical and experimental evidence","volume":"27","author":"Ehrlich","year":"2006","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.lfs.2024.122903_bb0370","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104762","article-title":"Anti-arrhythmic properties of non-antiarrhythmic medications","volume":"156","author":"Williams","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.lfs.2024.122903_bb0375","first-page":"12","article-title":"Angiotensin II and angiotensin II receptor blocker modulate the arrhythmogenic activity of pulmonary veins","volume":"147","author":"Chen","year":"2006"},{"key":"10.1016\/j.lfs.2024.122903_bb0380","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1093\/cvr\/28.2.201","article-title":"Fosinoprilate prolongs the action potential: reduction of iK and enhancement of the L-type calcium current in guinea pig ventricular myocytes","volume":"28","author":"R\u00e4cke","year":"1994","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.lfs.2024.122903_bb0385","first-page":"589","article-title":"The antiarrhythmic effect of the ACE inhibitor captopril in patients with congestive heart failure largely is due to its potassium sparing effects","volume":"8","author":"Poquet","year":"1992","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.lfs.2024.122903_bb0390","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ijcard.2009.07.015","article-title":"Enalapril, irbesartan, and angiotensin-(1-7) prevent atrial tachycardia-induced ionic remodeling","volume":"146","author":"Liu","year":"2011","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.lfs.2024.122903_bb0395","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s00210-014-1024-y","article-title":"Effect of fosinopril on the transient outward potassium current of hypertrophied left ventricular myocardium in the spontaneously hypertensive rat","volume":"387","author":"Huang","year":"2014","journal-title":"Naunyn Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"10.1016\/j.lfs.2024.122903_bb0400","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.hrthm.2009.05.014","article-title":"ACE I\/D polymorphism associated with abnormal atrial and atrioventricular conduction in lone atrial fibrillation and structural heart disease: implications for electrical remodeling","volume":"6","author":"Watanabe","year":"2009","journal-title":"Heart Rhythm."},{"key":"10.1016\/j.lfs.2024.122903_bb0405","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1515\/CCLM.2009.023","article-title":"Functional polymorphisms in ACE and CYP11B2 genes and atrial fibrillation in patients with hypertensive heart disease","volume":"47","author":"Huang","year":"2009","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.lfs.2024.122903_bb0410","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s00395-005-0571-2","article-title":"ACE-inhibitor treatment attenuates atrial structural remodeling in patients with lone chronic atrial fibrillation","volume":"101","author":"Boldt","year":"2006","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.lfs.2024.122903_bb0415","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/ncpcardio0480","article-title":"Drug Insight: angiotensin-converting-enzyme inhibitors and atrial fibrillation--indications and contraindications","volume":"3","author":"L\u00e9vy","year":"2006","journal-title":"Nature Clinical Practice. Cardiovascular medicine."},{"key":"10.1016\/j.lfs.2024.122903_bb0420","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1007\/s00392-019-01440-y","article-title":"Sacubitril\/valsartan reduces ventricular arrhythmias in parallel with left ventricular reverse remodeling in heart failure with reduced ejection fraction","volume":"108","author":"Martens","year":"2019","journal-title":"Clin. Res. Cardiol."},{"key":"10.1016\/j.lfs.2024.122903_bb0425","doi-asserted-by":"crossref","first-page":"5338","DOI":"10.1002\/ehf2.13623","article-title":"Impact of renin-angiotensin system inhibitors on long-term clinical outcomes of patients with rheumatic heart disease","volume":"8","author":"Liu","year":"2021","journal-title":"ESC Heart Fail."},{"key":"10.1016\/j.lfs.2024.122903_bb0430","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.7150\/ijbs.65802","article-title":"CXCR4-dependent macrophage-to-fibroblast signaling contributes to cardiac diastolic dysfunction in heart failure with preserved ejection fraction","volume":"18","author":"Zhang","year":"2022","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.lfs.2024.122903_bb0435","doi-asserted-by":"crossref","first-page":"H633","DOI":"10.1152\/ajpheart.00243.2021","article-title":"Immune cell beta(2)-adrenergic receptors contribute to the development of heart failure","volume":"321","author":"Tanner","year":"2021","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.lfs.2024.122903_bb0440","doi-asserted-by":"crossref","DOI":"10.1172\/JCI158703","article-title":"Macrophage efferocytosis with VEGFC and lymphangiogenesis: rescuing the broken heart","volume":"132","author":"D\u2019Amore","year":"2022","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.lfs.2024.122903_bb0445","doi-asserted-by":"crossref","DOI":"10.1172\/JCI140685","article-title":"Macrophage-produced VEGFC is induced by efferocytosis to ameliorate cardiac injury and inflammation","volume":"132","author":"Glinton","year":"2022","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.lfs.2024.122903_bb0450","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.ijcard.2009.09.524","article-title":"Reduction and activation of circulating dendritic cells in patients with decompensated heart failure","volume":"147","author":"Sugi","year":"2011","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.lfs.2024.122903_bb0455","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1161\/CIRCRESAHA.109.199802","article-title":"Myeloid differentiation factor-88\/interleukin-1 signaling controls cardiac fibrosis and heart failure progression in inflammatory dilated cardiomyopathy","volume":"105","author":"Blyszczuk","year":"2009","journal-title":"Circ. Res."},{"key":"10.1016\/j.lfs.2024.122903_bb0460","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1161\/CIRCULATIONAHA.120.051889","article-title":"Isolevuglandin-modified cardiac proteins drive CD4+ T-cell activation in the heart and promote cardiac dysfunction","volume":"143","author":"Ngwenyama","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.lfs.2024.122903_bb0465","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.780854","article-title":"Sialomucin CD43 plays a deleterious role in the development of experimental heart failure induced by pressure overload by modulating cardiac inflammation and fibrosis","volume":"12","author":"Kaur","year":"2021","journal-title":"Front. Physiol."},{"key":"10.1016\/j.lfs.2024.122903_bb0470","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1161\/CIRCULATIONAHA.117.030811","article-title":"Cardioprotective role of myeloid-derived suppressor cells in heart failure","volume":"138","author":"Zhou","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.lfs.2024.122903_bb0475","doi-asserted-by":"crossref","first-page":"4499","DOI":"10.4049\/jimmunol.0802740","article-title":"Myeloid-derived suppressor cells: linking inflammation and cancer","volume":"182","author":"Ostrand-Rosenberg","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.lfs.2024.122903_bb0480","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1042\/cs0920455","article-title":"Tissue expression of components of the renin-angiotensin system in experimental post-infarction heart failure in rats effects of heart failure and angiotensin-converting enzyme inhibitor treatment","volume":"92","author":"Kelly","year":"1997","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.lfs.2024.122903_bb0485","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.acthis.2014.08.006","article-title":"Cardiac and renal distribution of ACE and ACE-2 in rats with heart failure","volume":"116","author":"Cohen-Segev","year":"2014","journal-title":"Acta Histochem."},{"key":"10.1016\/j.lfs.2024.122903_bb0490","article-title":"Angiotensin-[1\u20137] attenuates kidney injury in experimental Alport syndrome","volume":"10","author":"Choi","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2024.122903_bb0495","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1161\/CIRCRESAHA.113.301141","article-title":"Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension","volume":"115","author":"Rabinovitch","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.lfs.2024.122903_bb0500","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1080\/21655979.2021.1936816","article-title":"Screening of key biomarkers and immune infiltration in pulmonary arterial hypertension via integrated bioinformatics analysis","volume":"12","author":"Zeng","year":"2021","journal-title":"Bioengineered"},{"key":"10.1016\/j.lfs.2024.122903_bb0505","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1161\/CIRCRESAHA.109.197533","article-title":"Inhibition of the SDF-1\/CXCR4 axis attenuates neonatal hypoxia-induced pulmonary hypertension","volume":"104","author":"Young","year":"2009","journal-title":"Circ. Res."},{"key":"10.1016\/j.lfs.2024.122903_bb0510","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1183\/09031936.00045710","article-title":"Targeting of c-kit+ haematopoietic progenitor cells prevents hypoxic pulmonary hypertension","volume":"37","author":"Gambaryan","year":"2011","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.lfs.2024.122903_bb0515","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cyto.2017.08.015","article-title":"Origin and production of inflammatory perivascular macrophages in pulmonary hypertension","volume":"100","author":"Florentin","year":"2017","journal-title":"Cytokine"},{"key":"10.1016\/j.lfs.2024.122903_bb0520","doi-asserted-by":"crossref","first-page":"3612","DOI":"10.4049\/jimmunol.1701287","article-title":"Inflammatory macrophage expansion in pulmonary hypertension depends upon mobilization of blood-borne monocytes","volume":"200","author":"Florentin","year":"2018","journal-title":"J. Immunol."},{"key":"10.1016\/j.lfs.2024.122903_bb0525","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1165\/rcmb.2016-0201OC","article-title":"Roles for the CX3CL1\/CX3CR1 and CCL2\/CCR2 chemokine Systems in Hypoxic Pulmonary Hypertension","volume":"56","author":"Amsellem","year":"2017","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.lfs.2024.122903_bb0530","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s10875-009-9322-8","article-title":"Impairment of monocyte-derived dendritic cells in idiopathic pulmonary arterial hypertension","volume":"29","author":"Wang","year":"2009","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.lfs.2024.122903_bb0535","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3389\/fimmu.2019.00011","article-title":"Dendritic cell subsets and effector function in idiopathic and connective tissue disease-associated pulmonary arterial hypertension","volume":"10","author":"van Uden","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2024.122903_bb0540","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/s41423-020-00608-1","article-title":"Interleukin-6 mediates neutrophil mobilization from bone marrow in pulmonary hypertension","volume":"18","author":"Florentin","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.lfs.2024.122903_bb0545","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1378\/chest.11-0205","article-title":"Circulating myeloid-derived suppressor cells are increased and activated in pulmonary hypertension","volume":"141","author":"Yeager","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.lfs.2024.122903_bb0550","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1158\/0008-5472.CAN-17-0348","article-title":"CCR5(+) myeloid-derived suppressor cells are enriched and activated in melanoma lesions","volume":"78","author":"Blattner","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.lfs.2024.122903_bb0555","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19082277","article-title":"Myeloid-derived suppressor cells and pulmonary hypertension","volume":"19","author":"Bryant","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2024.122903_bb0560","doi-asserted-by":"crossref","first-page":"11409","DOI":"10.1111\/jcmm.15745","article-title":"Transcriptomic analysis identifies toll-like and nod-like pathways and necroptosis in pulmonary arterial hypertension","volume":"24","author":"Xiao","year":"2020","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.lfs.2024.122903_bb0565","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/nrm.2016.149","article-title":"Necroptosis in development, inflammation and disease","volume":"18","author":"Weinlich","year":"2017","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.lfs.2024.122903_bb0570","first-page":"10532","article-title":"Sevoflurane improves circulatory function and pulmonary fibrosis in rats with pulmonary arterial hypertension through inhibiting NF-kappaB signaling pathway","volume":"23","author":"Zhao","year":"2019","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.lfs.2024.122903_bb0575","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222312800","article-title":"Alternative RAS in various hypoxic conditions: from myocardial infarction to COVID-19","volume":"22","author":"Rajtik","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2024.122903_bb0580","first-page":"1016","article-title":"Angiotensin converting enzyme inhibitors and pulmonary hypertension","volume":"116","author":"Martiniuc","year":"2012","journal-title":"Rev. Med. Chir. Soc. Med. Nat. Iasi"},{"issue":"2016","key":"10.1016\/j.lfs.2024.122903_bb0585","first-page":"67","volume":"37","author":"Gali\u00e8","year":"2015","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.lfs.2024.122903_bb0590","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/s41587-020-00796-1","article-title":"Hypertension delays viral clearance and exacerbates airway hyperinflammation in patients with COVID-19","volume":"39","author":"Trump","year":"2021","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.lfs.2024.122903_bb0595","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jaci.2022.05.019","article-title":"Preexisting comorbidities shape the immune response associated with severe COVID-19","volume":"150","author":"Kreutmair","year":"2022","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.lfs.2024.122903_bb0600","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.tips.2004.04.001","article-title":"ACE2: from vasopeptidase to SARS virus receptor","volume":"25","author":"Turner","year":"2004","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.lfs.2024.122903_bb0605","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1056\/NEJMsr2005760","article-title":"Renin\u2013angiotensin\u2013aldosterone system inhibitors in patients with Covid-19","volume":"382","author":"Vaduganathan","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lfs.2024.122903_bb0610","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0288338","article-title":"Angiotensin-converting enzyme (ACE) level, but not ACE gene polymorphism, is associated with prognosis of COVID-19 infection: implications for diabetes and hypertension","volume":"18","author":"Elbasan","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2024.122903_bb0615","first-page":"1462","article-title":"The renin-angiotensin system in COVID-19: can long COVID be predicted?","volume":"13","author":"K\u00f6nig","year":"2023","journal-title":"Life (Basel, Switzerland)"},{"key":"10.1016\/j.lfs.2024.122903_bb0620","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12985-023-02283-w","article-title":"BwKrhs-Covid-research-group, impact of ACE I gene insertion\/deletion, A-240T polymorphisms and the renin-angiotensin-aldosterone system on COVID-19 disease","volume":"21","author":"Zobel","year":"2024","journal-title":"Virol. J."},{"key":"10.1016\/j.lfs.2024.122903_bb0625","first-page":"L213","article-title":"A pilot study to assess the circulating renin-angiotensin system in COVID-19 acute respiratory failure","volume":"321","author":"Files","year":"2021","journal-title":"Am. J. Phys. Lung Cell. Mol. Phys."},{"key":"10.1016\/j.lfs.2024.122903_bb0630","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1161\/HYPERTENSIONAHA.121.18295","article-title":"Dysregulation of ACE (angiotensin-converting enzyme)-2 and renin-angiotensin peptides in SARS-CoV-2 mediated mortality and end-organ injuries","volume":"79","author":"Wang","year":"2022","journal-title":"Hypertension"},{"key":"10.1016\/j.lfs.2024.122903_bb0635","doi-asserted-by":"crossref","first-page":"7678","DOI":"10.3390\/ijms24087678","article-title":"rs1799752 variant is associated with COVID-19 severity but is independent of serum ACE activity in hospitalized and recovered patients","volume":"24","author":"Fricke-Galindo","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2024.122903_bb0640","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1007\/s00011-023-01775-3","article-title":"ACE2, ACE, DPPIV, PREP and CAT L enzymatic activities in COVID-19: imbalance of ACE2\/ACE ratio and potential RAAS dysregulation in severe cases","volume":"72","author":"Neves","year":"2023","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.lfs.2024.122903_bb0645","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/s41569-020-0360-5","article-title":"COVID-19 and the cardiovascular system","volume":"17","author":"Zheng","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.lfs.2024.122903_bb0650","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.026143","article-title":"COVID-METARASI consortium, renin-angiotensin system inhibitors in patients with COVID-19: a Meta-analysis of randomized controlled trials led by the international society of hypertension","volume":"11","author":"Gnanenthiran","year":"2022","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.lfs.2024.122903_bb0655","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s11906-022-01207-3","article-title":"Renin-angiotensin-aldosterone inhibitors and COVID-19 infection","volume":"24","author":"Tsampasian","year":"2022","journal-title":"Curr. Hypertens. Rep."},{"key":"10.1016\/j.lfs.2024.122903_bb0660","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.108146","article-title":"Renin-angiotensin system inhibitor discontinuation in COVID-19 did not modify systemic ACE2 in a randomized controlled trial","volume":"26","author":"Rathkolb","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.lfs.2024.122903_bb0665","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1093\/ehjcvp\/pvad067","article-title":"Effects of renin-angiotensin system blockers on outcomes from COVID-19: a systematic review and meta-analysis of randomized controlled trials","volume":"10","author":"Lee","year":"2024","journal-title":"European heart journal. Cardiovascular pharmacotherapy."},{"key":"10.1016\/j.lfs.2024.122903_bb0670","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.therap.2020.05.009","article-title":"Drugs acting on renin angiotensin system and use in ill patients with COVID-19","volume":"75","author":"Alexandre","year":"2020","journal-title":"Therapies"},{"key":"10.1016\/j.lfs.2024.122903_bb0675","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1056\/NEJMsr2005760","article-title":"Renin-angiotensin-aldosterone system inhibitors in patients with Covid-19","volume":"382","author":"Vaduganathan","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lfs.2024.122903_bb0680","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1001\/jama.2020.11301","article-title":"Association of Angiotensin-Converting Enzyme Inhibitor or angiotensin receptor blocker use with COVID-19 diagnosis and mortality","volume":"324","author":"Fosbol","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.lfs.2024.122903_bb0685","article-title":"The association of COVID-19 occurrence and severity with the use of angiotensin converting enzyme inhibitors or angiotensin-II receptor blockers in patients with hypertension","volume":"16","author":"Li","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2024.122903_bb0690","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1161\/CIRCRESAHA.120.317134","article-title":"Association of Inpatient use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19","volume":"126","author":"Zhang","year":"2020","journal-title":"Circ. Res."},{"key":"10.1016\/j.lfs.2024.122903_bb0695","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107750","article-title":"A comprehensive guide to the pharmacologic regulation of angiotensin converting enzyme 2 (ACE2), the SARS-CoV-2 entry receptor","volume":"221","author":"Oz","year":"2021","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.lfs.2024.122903_bb0700","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.tips.2008.05.003","article-title":"Role of the renin-angiotensin system in vascular inflammation","volume":"29","author":"Marchesi","year":"2008","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.lfs.2024.122903_bb0705","doi-asserted-by":"crossref","first-page":"23496","DOI":"10.1074\/jbc.M110.117481","article-title":"Angiotensin-converting enzyme inhibition down-regulates the pro-atherogenic chemokine receptor 9 (CCR9)-chemokine ligand 25 (CCL25) axis","volume":"285","author":"Abd Alla","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2024.122903_bb0710","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/0002-8703(92)90281-Y","article-title":"Effect of captopril on the prevention and regression of myocardial cell hypertrophy and interstitial fibrosis in pressure overload cardiac hypertrophy","volume":"124","author":"Rossi","year":"1992","journal-title":"Am. Heart J."},{"key":"10.1016\/j.lfs.2024.122903_bb0715","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2023.105636","article-title":"SARS-CoV-2 induces cardiomyocyte apoptosis and inflammation but can be ameliorated by ACE inhibitor captopril","volume":"215","author":"Huang","year":"2023","journal-title":"Antivir. Res."},{"key":"10.1016\/j.lfs.2024.122903_bb0720","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-43099-6","article-title":"Effects of the angiotensin-converting enzyme inhibitor captopril on occlusal-disharmony-induced cardiac dysfunction in mice","volume":"13","author":"Ito","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2024.122903_bb0725","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2021.109732","article-title":"Targeting inflammation and redox aberrations by perindopril attenuates methotrexate-induced intestinal injury in rats: role of TLR4\/NF-\u03baB and c-Fos\/c-Jun pro-inflammatory pathways and PPAR-\u03b3\/SIRT1 cytoprotective signals","volume":"351","author":"Sayed","year":"2022","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.lfs.2024.122903_bb0730","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ijcard.2007.04.062","article-title":"Comparison of angiotensin converting enzyme inhibition and angiotensin II receptor blockade for the prevention of experimental autoimmune myocarditis","volume":"125","author":"Bahk","year":"2008","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.lfs.2024.122903_bb0735","article-title":"Captopril attenuates TAC-induced heart failure via inhibiting Wnt3a\/\u03b2-catenin and Jak2\/Stat3 pathways","volume":"113","author":"Zhang","year":"2019","journal-title":"Iomedicine & Pharmacotherapy"},{"key":"10.1016\/j.lfs.2024.122903_bb0740","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1336102","article-title":"JAK\/STAT3 signaling in cardiac fibrosis: a promising therapeutic target","volume":"15","author":"Jiang","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.lfs.2024.122903_bb0745","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0292624","article-title":"Oral angiotensin-converting enzyme inhibitor captopril protects the heart from Porphyromonas gingivalis LPS-induced cardiac dysfunction in mice","volume":"18","author":"Kiyomoto","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2024.122903_bb0750","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1124\/mol.105.020636","article-title":"Angiotensin-converting enzyme (ACE) dimerization is the initial step in the ACE inhibitor-induced ACE signaling cascade in endothelial cells","volume":"69","author":"Kohlstedt","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.lfs.2024.122903_bb0755","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1124\/mol.117.110866","article-title":"Investigation into the mechanism of Homo- and Heterodimerization of angiotensin-converting enzyme","volume":"93","author":"Abrie","year":"2018","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.lfs.2024.122903_bb0760","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-08534-0","article-title":"Beta-blocker\/ACE inhibitor therapy differentially impacts the steady state signaling landscape of failing and non-failing hearts","volume":"12","author":"Sorrentino","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2024.122903_bb0765","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with Canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lfs.2024.122903_bb0770","article-title":"Abrogation of CC chemokine receptor 9 ameliorates ventricular remodeling in mice after myocardial infarction","volume":"6","author":"Huang","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2024.122903_bb0775","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.716219","article-title":"Abrogation of CC chemokine receptor 9 ameliorates ventricular electrical remodeling in mice after myocardial infarction","volume":"8","author":"Huang","year":"2021","journal-title":"Front Cardiovasc Med."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320524004934?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320524004934?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T13:35:58Z","timestamp":1721914558000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320524004934"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":155,"alternative-id":["S0024320524004934"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2024.122903","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of angiotensin converting enzyme in pathogenesis associated with immunity in cardiovascular diseases","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2024.122903","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"122903"}}